Table 2.
Comparison of serum LAPTM4B levels in breast cancer patients and normal controls (median (IQR)).
| Group | Number | LAPTM4B (ng/mL) | p value |
|---|---|---|---|
| Controls | 80 | 2.01 (2.36) | p < 0.001 |
| BC (stage I + II) | 250 | 8.85 (15.40) | |
| BC (stage III + IV) | 176 | 13.91 (35.33) |
Comparison of serum LAPTM4B levels in breast cancer patients and normal controls (median (IQR)).
| Group | Number | LAPTM4B (ng/mL) | p value |
|---|---|---|---|
| Controls | 80 | 2.01 (2.36) | p < 0.001 |
| BC (stage I + II) | 250 | 8.85 (15.40) | |
| BC (stage III + IV) | 176 | 13.91 (35.33) |